CCS
VASC

Crosspoint Capital Strategies’s Vascular Solutions Inc VASC Stock Holding History

Crosspoint Capital Strategies’s Portfolio VASC Stock Details VASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-250
Closed -$7K – 685
2014
Q1 		$7K Buy
+250
New +$6.22K ﹤0.01% 537

Other funds holding VASC

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACMM
Arbor Capital Management (Minnesota) Minneapolis, Minnesota $190M AUM 10.8% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Crosspoint Capital Strategies's VASC Position: Q2 2014 in Review

Crosspoint Capital Strategies sold out of Vascular Solutions Inc (VASC) in Q2 2014, closing a stake of 250 shares — an estimated $7K sold.

Crosspoint Capital Strategies first reported a position in VASC in Q1 2014 and held it in 1 quarter. The position peaked at $7K in Q1 2014. 99 funds tracked by Wall St. Rank hold VASC as of Q2 2014.

  • Crosspoint Capital Strategies reported no remaining Vascular Solutions Inc position as of Q2 2014 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 250 Vascular Solutions Inc shares in Q2 2014, an estimated $7K.
  • Crosspoint Capital Strategies first reported a position in Vascular Solutions Inc in Q1 2014 and held it in 1 quarter.
  • Crosspoint Capital Strategies's Vascular Solutions Inc position peaked at $7K in Q1 2014.
  • 99 funds tracked by Wall St. Rank held Vascular Solutions Inc as of Q2 2014.

Based on Crosspoint Capital Strategies's 13F filing for Q2 2014, filed 29 Jul 2014.